Search Autoimmune Association
Share this article
Us Capitol Building

Autoimmune Association Leads Sign-On Letter, 64 Patient Groups Ask Congress to Protect Rare Disease Drug Development

December 2021– In a letter sent December 14 to congressional leadership, 64 patient organizations signed on to the Autoimmune Association’s letter asking congress to remove a provision from the currently drafted text of the Build Back Better Act that would dramatically curtail the Orphan Drug Tax Credit for qualified clinical testing expenses by removing a critical incentive for all but the first approved orphan use of a new drug.

Over 90% of rare diseases lack an FDA-approved treatment indicated for the specific rare disease, and since 2016 alone, 23 secondary orphan drug indications have been FDA approved for rare autoimmune diseases. At such a promising time, Congress should be protecting and investing in the future of those without a current FDA approved treatment, rather than removing incentives for the development of future therapies for those who depend on it the most.  Click here to read the full letter.

Share this article

Join our email list

Receive the latest blog articles, news, and more right to your inbox!

Related articles you might be interested in

Us Capitol Building

Autoimmune Association Leads Sign-On Letter, Supported by 24 Patient Groups

March 2022- The Autoimmune Association led a sign-on letter supported by 24 organizations calling on Congress to include an increase in its supplemental...
pen

Autoimmune Association Leads Sign-On Letter for 2023 NBPP Proposed Rule, Highlights Lack of Language Protecting Copay Assistance

The Autoimmune Association led a sign-on letter commenting on the HHS Notice of Benefit and Payment Parameters for 2023. The proposed rule includes...
Capitol Hhs Rule Scaled

Autoimmune Association and 50+ Patient Groups Send Letter to Key Members of Congress on Drug Pricing Priorities for Autoimmune Patients

Washington, DC, July 30, 2021 – Autoimmune Association sent a letter to key members of Congress with the undersigned 50+ patient groups on...
Cigna Blog Scaled

Non-Medical Switching: A Threat to Patient Health and Wellness

By Lilly Stairs, Founder of Patient Authentic and Interim CEO, AARDA Non-medical switching is a dangerous practice that affects too many patients each...

Find more resources on autoimmunity

Learn more about autoimmunity, diagnosis tips, how to find a physician, and more.